Glucocorticoid versus immunoglobulin in the treatment of COVID-19-associated fulminant myocarditis

Chia Siang Kow; Syed Shahzad Hasan

doi:10.1007/s15010-020-01441-4

Glucocorticoid versus immunoglobulin in the treatment of COVID-19-associated fulminant myocarditis

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	805-806
Number of pages	2
Journal	Infection
Volume	48
Issue number	5
Early online date	10 May 2020
DOIs	https://doi.org/10.1007/s15010-020-01441-4
Publication status	Published - 1 Oct 2020

Access to Document

10.1007/s15010-020-01441-4Licence: Unspecified

Cite this

@article{93763abad8bc4b13b7d697434c6cbcee,

title = "Glucocorticoid versus immunoglobulin in the treatment of COVID-19-associated fulminant myocarditis",

keywords = "Glucocorticoid, immunoglobulin, COVID‑19",

author = "Kow, {Chia Siang} and Hasan, {Syed Shahzad}",

year = "2020",

month = oct,

day = "1",

doi = "10.1007/s15010-020-01441-4",

language = "English",

volume = "48",

pages = "805--806",

journal = "Infection",

issn = "0300-8126",

publisher = "Urban und Vogel",

number = "5",

}

TY - JOUR

T1 - Glucocorticoid versus immunoglobulin in the treatment of COVID-19-associated fulminant myocarditis

AU - Kow, Chia Siang

AU - Hasan, Syed Shahzad

PY - 2020/10/1

Y1 - 2020/10/1

KW - Glucocorticoid

KW - immunoglobulin

KW - COVID‑19

UR - http://www.scopus.com/inward/record.url?scp=85084381774&partnerID=8YFLogxK

U2 - 10.1007/s15010-020-01441-4

DO - 10.1007/s15010-020-01441-4

M3 - Letter

C2 - 32388676

VL - 48

SP - 805

EP - 806

JO - Infection

JF - Infection

SN - 0300-8126

IS - 5

ER -

Glucocorticoid versus immunoglobulin in the treatment of COVID-19-associated fulminant myocarditis

Access to Document

Other files and links

Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19

Is it worth the wait? Should Chloroquine or Hydroxychloroquine be allowed for immediate use in CoViD-19?

Cite this